# Chemokine Receptor Profile of Circulating Leukocyte Subsets in Response to Acute High-Intensity Interval Training

**Authors:** Katharina Leuchte, Sara Fresnillo Saló, Anne Rahbech, Mikkel Byrdal, Anders Vinther, Gitte Holmen Olofsson

PMC · DOI: 10.3390/biom16020263 · Biomolecules · 2026-02-07

## TL;DR

This study shows that high-intensity interval training rapidly changes immune cell profiles, suggesting improved immune response and tissue targeting.

## Contribution

The study reveals specific chemokine receptor profiles of immune cells mobilized by acute HIIT, linking exercise to enhanced immune cell migration.

## Key findings

- HIIT rapidly mobilizes NK cells, CD4+ T cells, and γδ T cells with specific chemokine receptor profiles.
- CX3CR1+ CXCR2+ CD56dim NK cells and CX3CR1+ CD56+ γδ T cells are preferentially mobilized after HIIT.
- Intermediate and non-classical monocytes increase immediately after HIIT and return to baseline later.

## Abstract

Physically active individuals demonstrate enhanced immune competence. Efficient execution of effector function relies on chemokine receptor-regulated immune cell trafficking along chemokine gradients to sites of inflammation, infection, tumors, or tissue damage. This study investigates the impact of acute high-intensity interval training (HIIT) on chemokine receptor expression in leukocytes. Sixteen healthy participants completed a single HIIT session, and peripheral blood was collected before exercise (Bsl), immediately after (Ex02), and one hour later (Ex60). Surface expression of selected chemokine receptors was measured using flow cytometry on CD4+ T cells, γδ T cells, NK cells, and monocytes, followed by FlowSOM clustering. NK cells, CD4+ T cells, and γδ T cells were strongly mobilized at Ex02 and returned to or below baseline at Ex60. HIIT preferentially mobilized CX3CR1+ CXCR2+ CD56dim NK cells, CD4+ T cells expressing CX3CR1hi and CCR5+, and CX3CR1+ CD56+ γδ T cells, indicating mobilization of immune cells phenotypically associated with migratory and cytotoxic potential. Proportions of intermediate and non-classical monocytes increased at Ex02 and decreased at Ex60. In conclusion, HIIT induced a rapid redistribution of leukocyte subsets with chemokine receptor profiles suggesting enhanced endothelial interaction and migratory capacity toward effector tissues.

## Linked entities

- **Proteins:** CX3CR1 (C-X3-C motif chemokine receptor 1), CXCR2 (C-X-C motif chemokine receptor 2), NCAM1 (neural cell adhesion molecule 1), CCR5 (C-C motif chemokine receptor 5)

## Full-text entities

- **Genes:** CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363] {aka CKb11, ELC, MIP-3b, MIP3B, SCYA19}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, POP5 (POP5 ribonuclease P/MRP subunit) [NCBI Gene 51367] {aka HSPC004, RPP2, RPP20, hPop5}, CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283] {aka CMK, Humig, MIG, SCYB9, crg-10}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Cxcr2 (C-X-C motif chemokine receptor 2) [NCBI Gene 12765] {aka CD128, CDw128, Cmkar2, Gpcr16, IL-8Rh, IL-8rb}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, PYDC5 (pyrin domain containing 5) [NCBI Gene 107181291] {aka POP3}, CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 729230] {aka CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CCL21 (C-C motif chemokine ligand 21) [NCBI Gene 6366] {aka 6Ckine, CKb9, ECL, SCYA21, SLC, TCA4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD14 (CD14 molecule) [NCBI Gene 929], CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, POP1 (POP1 ribonuclease P/MRP subunit) [NCBI Gene 10940] {aka ANXD2}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, POP4 (POP4 ribonuclease P/MRP subunit) [NCBI Gene 10775] {aka RPP29}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, Cx3cl1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 20312] {aka ABCD-3, CX3C, Cxc3, D8Bwg0439e, FK, Scyd1}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}
- **Diseases:** injury to (MESH:D014947), chronic inflammation (MESH:D007249), cancer (MESH:D009369), autoimmune and inflammatory disease (MESH:D001327), obesity (MESH:D009765), HIIT (MESH:D000095027), RA (MESH:D001172), monocytosis (MESH:C538328), infection (MESH:D007239), cytotoxic (MESH:D064420), leukocytosis (MESH:D007964), multiple sclerosis (MESH:D009103), infectious disease (MESH:D003141)
- **Chemicals:** epinephrine (MESH:D004837), water (MESH:D014867), norepinephrine (MESH:D009638), RMPI medium (-), caffeine (MESH:D002110), catecholamines (MESH:D002395), prednisone (MESH:D011241), PBS (MESH:D007854), alcohol (MESH:D000438), Sodium Heparin (MESH:D006493)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937720/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937720/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937720/full.md

---
Source: https://tomesphere.com/paper/PMC12937720